Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Loading GALE News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||1.31%||67.12||1.0%||$477.88m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.13%||372.43||2.7%||$322.82m|
|VRTX||Vertex Pharmaceuticals Incorporated||-0.33%||117.27||1.8%||$289.46m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.85%||120.55||1.6%||$218.34m|
|NBIX||Neurocrine Biosciences, Inc.||3.55%||53.62||4.5%||$102.87m|
|BMRN||BioMarin Pharmaceutical Inc.||0.72%||94.19||4.3%||$98.65m|
|KITE||Kite Pharma, Inc.||-2.04%||80.57||15.6%||$97.22m|
|CLVS||Clovis Oncology, Inc.||1.65%||57.86||18.2%||$93.56m|
|A||Agilent Technologies, Inc.||0.70%||54.82||1.6%||$87.06m|
Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs. It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.